# IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions

> **NCT02930122** · PHASE2 · TERMINATED · sponsor: **Cale Jacobs, PhD** · enrollment: 6 (actual)

## Conditions studied

- Anterior Cruciate Ligament Tear

## Interventions

- **DRUG:** anakinra (150mg)
- **OTHER:** Saline intraarticularly

## Key facts

- **NCT ID:** NCT02930122
- **Lead sponsor:** Cale Jacobs, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-20
- **Primary completion:** 2020-10-16
- **Final completion:** 2020-10-16
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02930122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02930122, "IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02930122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*